Systemic lupus erythromatosus

53
Dr Habeeb Resident Medicine Unit- 1 BMCH

Transcript of Systemic lupus erythromatosus

Page 1: Systemic lupus erythromatosus

Dr HabeebResident

Medicine Unit-1BMCH

Page 2: Systemic lupus erythromatosus

Introduction

Systemic Lupus erythromatosus is a rare, autoimmune based chronic inflammatory disease of un-known aetiology.

Maybe confined to the skin or may involve multiple organs system.

Some 90% of affected patients are female.

Peak age at onset is 20 to 30 years.

Lupus is associated with morbidity and a five-fold increase in mortality mainly because of an increased risk of premature cardiovascular disease.

Most common cause of death are infections and Renal Failure.

Page 3: Systemic lupus erythromatosus

Pathophysiology

SLE is characterized by hyper-reactivity of B lymphocytes, hypergammaglobulinaemia, multiple autoantibodies, circulating immune complexes, and complement activation (low C3 , C4).

Autoantibodies to self antigens, increased apoptosis and impaired clearance of apoptotic bodies play an important role. Tissue damage is the result of immune complex deposition as well as direct cellular injury.

Page 4: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional SymptomsPatient may present with symptoms such as Fever, Weight loss , fatigue and malaise

Page 5: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional Symptoms2. Arthritis

Arthralgia is a common symptom, occurring in 90% ofpatients, and is often associated with early morning stiffness, joint deformity may occur but erosion does not.

Page 6: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional Symptoms2. Arthritis3. Raynaud’s Phenomenon

Raynaud’s associated with SLE needs to be differentiated from primary Raynaud’s, which is common in healthy young women.

Page 7: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional Symptoms2. Arthritis3. Raynaud’s Phenomenon4. Skin involvement

3 types of skin lesions:Malar Rash classically butterfly rash, Discoid Rash which is scaring and may cause Alopecia if on scalp & subacute cutaneous lupus erythromatosus rash which is migratory and non-scaring

Page 8: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional Symptoms2. Arthritis3. Raynaud’s Phenomenon4. Skin involvement5. Kidney

Typical renal lesion is a proliferative glomerulonephiritis , characterized by haematuria, proteinuria and casts on urine microscopy.

Page 9: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional Symptoms2. Arthritis3. Raynaud’s Phenomenon4. Skin involvement5. Kidney6. Cardiovascular

Pericarditis, Myocarditis & less commonly Libman–Sacks endocarditis can occur. Increased risk of stroke & MI due to increased atherosclerosis.

Page 10: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional Symptoms2. Arthritis3. Raynaud’s Phenomenon4. Skin involvement5. Kidney6. Cardiovascular7. Lungs

Lung involvement manifests as pleurisy or pleural effusion. Other features include pneumonitis, atelectasis, reduced lung volume and pulmonary fibrosis.

Page 11: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional Symptoms2. Arthritis3. Raynaud’s Phenomenon4. Skin involvement5. Kidney6. Cardiovascular7. Lungs8. Neurological

Fatigue, headache and poor concentration are common. More specific features of cerebral lupus include visual hallucinations, chorea, organic psychosis, transverse myelitis and lymphocytic meningitis.

Page 12: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional Symptoms2. Arthritis3. Raynaud’s Phenomenon4. Skin involvement5. Kidney6. Cardiovascular7. Lungs8. Neurological9. Hematological

Neutropenia, lymphopenia, thrombocytopenia orhaemolytic anaemia may occur, due to antibody mediated destruction of peripheral blood cells.

Page 13: Systemic lupus erythromatosus

History and Examination…..

1. Constitutional Symptoms2. Arthritis3. Raynaud’s Phenomenon4. Skin involvement5. Kidney6. Cardiovascular7. Lungs8. Neurological9. Hematological10.Gastrointestinal

Mouth ulcers may occur and may or may not be painful.Mesenteric vasculitis is a serious complication, which can present with abdominal pain, bowel infarction or perforation.

Page 14: Systemic lupus erythromatosus

Diagnostic Criteria

Page 15: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Fixed erythema, flat or raised over the malar eminences, sparing the nasolabial folds

Page 16: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Oral or nasopharyngeal ulceration, usuallypainless

Page 17: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Erythematous raised patches with adherent keratotic scaling and follicular plugging; atrophic scarring may occur in the older lesions

Page 18: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Haemolytic anaemia, leucopaenia (<4000 mm),lymphopaenia (<1500/mm), thrombocytopaenia(<100,000/mm

Page 19: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Persistent proteinuria greater than 0.5 gm/dayor greater than 3+ on dipstick or Cellular casts

Page 20: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Seizures or psychosis, other causes ruled out

Page 21: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Skin rash on exposed areas as a result of unusual reaction to sunlight

Page 22: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Non-erosive arthritis involving two or moreperipheral joints, characterised by tenderness,swelling or effusion

Page 23: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Anti-DNA antibodies in abnormal titre or presence of antibody to Sm antigen or positive antiphospholipid antibodies

Page 24: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

Pleuritis, by history of pleuritic pain or rub heard by a physician or evidence of pleural effusion on CXR or CT or Pericarditis by ECG or evidence of pericardial effusion

Page 25: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

A significant titre by ImmunoFlurescent method in the absence of the other causes of positive ANA

Page 26: Systemic lupus erythromatosus

Diagnostic Criteria

1. Malar Rash2. Oral Ulcers3. Discoid Rash4. E “Hematological”5. Renal Involvement6. Neurological 7. Photosensitivity8. Arthritis9. Immunological10.Serositis11.ANA

Mnemonic “Modern Paisa” to memorize the criteria

A significant titre by ImmunoFlurescent method in the absence of the other causes of positive ANA

Page 27: Systemic lupus erythromatosus

Workup…

Page 28: Systemic lupus erythromatosus

Workup…

Blood CP Anemia,Leukopenia & Thrombocytopenia which characterize active Lupus

Following biochemical investigations are routinely carried out:

Page 29: Systemic lupus erythromatosus

Workup…

Blood CP

Urine AnalysisHematuria, Proteinuria, Casts

Following biochemical investigations are routinely carried out:

Page 30: Systemic lupus erythromatosus

Workup…

Blood CP

Urine Analysis

Creatinine

Routinely done to assess Kidney function

Following biochemical investigations are routinely carried out:

Page 31: Systemic lupus erythromatosus

Workup…

Blood CP

Urine Analysis

Creatinine

ESR

Routinely done to assess Kidney function

Following biochemical investigations are routinely carried out:

Page 32: Systemic lupus erythromatosus

Workup…

These are repeated periodically (monthly or at longer intervals).Immunology investigations

• ANA (not required to be repeated)• Anti-dsDNA• ENAs (Antibodies to extractable nuclear an(SSA), La (SSB), Smith etc.• C3, C4• Antiphospholipid antibodies

Others:X-ray chest

Page 33: Systemic lupus erythromatosus

Investigations Depending on Systemic Involvement

Workup…

Page 34: Systemic lupus erythromatosus

Disease Activity Assessment

Page 35: Systemic lupus erythromatosus

Disease Activity Assessment

Periodic CBC and urine analysis are mandatory. Active lupus is characterised by anaemia, leucopaenia,

lymphopaenia, and thrombocytopaenia Proteinuria and active urinary sediment point to active

glomerulonephritis. Rising anti-dsDNA titres and falling C3 C4 levels.

Page 36: Systemic lupus erythromatosus
Page 37: Systemic lupus erythromatosus

Treatment

Page 38: Systemic lupus erythromatosus

Prevention

All patients with lupus erythematosus should be counseled on photoprotection, including protecting skin from sunlight and avoiding sun exposure during peak hours (i.e., between 10 AM and 2 PM).

Broad-spectrum sunscreen that contains titanium, zinc, Mexoryl (L’Oreal), or Helioplex(Neutrogena) should be used whenever patients are outdoors.

Photoprotective clothing, available from multiple vendors, is useful for limiting sun exposure.

Page 39: Systemic lupus erythromatosus

Medium-potency topical corticosteroidsUse of triamcinolone 0.1% cream (Flutex) for lesions on the head and neck up to 2 weeks

Foam or liquid- or lotion based corticosteroids for the scalp lesions.Intralesional corticosteroids may cause mild discomfort, atrophy of the skin or subcutis, or stretch marks. Topical calcineurin inhibitors such as pimecrolimus (Elidel) or tacrolimus (Protopic) may be used for maintenance treatment Recurrent or refractory lesions require systemic treatment.

Treatment of Cutaneous Lupus Erythematosus

Page 40: Systemic lupus erythromatosus

Antimalarials hydroxychloroquine (HCQ) are disease-modifying agents that limit the progression of lupus.

Hydroxychloroquine at 200 mg daily for 2 weeks and then increased to 400 mg daily.

Hydroxychloroquine exerts its effects within 2 to 3 months of beginning treatment.

Treatment of Systemic Lupus Erythematosus

Page 41: Systemic lupus erythromatosus

• Depending on end-organ involvement in SLE, immunosuppression with systemic corticosteroids such as prednisone at doses of 1 mg/kg/day is appropriate.

• Steroid-sparing drugs such as methotrexate , acitretin or mycophenolate mofetil are added.

Treatment of Systemic Lupus Erythematosus cont……

Page 42: Systemic lupus erythromatosus

Arthralgia can usually be managed with acetaminophen or nonsteroidal antiinflammatory drugs (NSAIDs). Hydroxychloroquine 200 mg twice daily can be added. Methotrexate 7.5 to 25 mg PO once weekly with folic acid 1mg daily .Azathioprine (Imuran) 0.5 to 2 mg/kg with monitoring of CBC & LFTs. Low-dose glucocorticoids (prednisone 5–10 mg/day) may be used as a bridge to steroid-sparing therapy and to treat intermittent flares.

Treatment of Musculoskeletal Manifestations

Page 43: Systemic lupus erythromatosus

Lupus Nephritis is one of the severe manifestation of renal disease and Treatment should be coordinated with a rheumatologist or nephrologist.

Class I disease no therapy.

Class II can be treated with prednisone (20 mg/day for 6 weeks to 3 months)Class III and IV disease treated with prednisone(1 mg/kg/day) for 6 weeks ,maintenance of 10 to 15 mg/day. In addition cytotoxic therapy with Cyclophosphamide 0.5 to 1 g/m BSA monthly for 6 months and tapered to every 3 monthsClass V disease can be treated with prednisone alone, similar to class II disease

Treatment of Renal Manifestations

Page 44: Systemic lupus erythromatosus

Neuropsychiatric Symptoms can range from mild to severe headache, aseptic meningitis, neuropathy, myelopathy, cognitive dysfunction, seizures, cerebritis, and stroke.

For seizures, antiepileptic therapy is used.

Lupus cerebritis and transverse myelitis are two of the more serious manifestations that need to be treated emergently with aggressive immunosuppression.

Treatment includes high-dose corticosteroids and cyclophosphamide, similar to treatment for lupus nephritis.

Treatment of Nervous System Manifestations

Page 45: Systemic lupus erythromatosus

SPECIAL PROBLEMS

Fertility, Pregnancy, Contraception

Infections

SLE in Elderly

Page 46: Systemic lupus erythromatosus

• Steroids, hydroxychloroquine, and azathioprine can be continued during pregnancy.

• Cyclophosphamide, methotrexate, and mycophenolate should be discontinued 3 to 6 months before conception.

• Cyclophosphamide therapy carries the risk of age dependent ovarian failure.

• Intrauterine contraceptive devices should be avoided.• Oestrogen-containing contraceptives should be avoided with

APS

Fertility, Pregnancy, Contraception

Page 47: Systemic lupus erythromatosus

• Patients with SLE are particularly susceptible to infections • Candida, Herpes, Salmonella & Mycobacteria and capsulated

organisms (Pneumococcus, Meningococcus and H. influenzae).

• Increased susceptibility is due to low complement levels, prednisolone (>20 mg/d), immunosuppressives, splenic hypofunction.

• Prevention of infection with chemoprophylaxis and vaccination is advised.

Infections

Page 48: Systemic lupus erythromatosus

• SLE in the elderly is a milder disease.• Characterized by insidious onset, longer duration of disease• Lower incidence of renal, musculoskeletal, skin and

neurological manifestations.

SLE in Elderly

Page 49: Systemic lupus erythromatosus

Drug-Induced SLE

Page 50: Systemic lupus erythromatosus

• ANA, anti-histone antibodies, and LE cells are characteristic features of drug induced SLE.

• Clinical features are mild; renal and neurological involvement

is rare.

• Symptoms resolve on withdrawal of the offending drug

• Antibody titres may continue to remain elevated for a long time.

Drug-Induced SLE

Page 51: Systemic lupus erythromatosus

Drug-Induced SLE

o Procainamideo Quinidine

o Hydralazineo Methyldopao Chlorpromazineo Isoniazid

More commonly

Less common

Page 52: Systemic lupus erythromatosus
Page 53: Systemic lupus erythromatosus